Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Sipuleucel-T |
Trade Name | Provenge |
Synonyms | APC 8015 |
Drug Descriptions |
Provenge (sipuleucel-T) is composed of autologous dendritic cells exposed to a PAP-GCSF fusion protein (PA2024), which stimulates a cytotoxic immune response towards PAP-expressing tumor cells (PMID: 25565923, PMID: 25708576). |
DrugClasses | |
CAS Registry Number | 917381-47-6 |
NCIT ID | C1985 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Sipuleucel-T | Atezolizumab Sipuleucel-T | 0 | 1 |
Docetaxel + Sipuleucel-T | Docetaxel Sipuleucel-T | 0 | 2 |
Sipuleucel-T | Sipuleucel-T | 0 | 9 |